Global and Japan Famciclovir Market Insights, Forecast to 2026

Publisher Name :
Date: 23-Nov-2020
No. of pages: 148
Inquire Before Buying

Famciclovir market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Famciclovir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Famciclovir market is segmented into

- 125 mg Tablets

- 250 mg Tablets

- 500 mg Tablets

Segment by Application, the Famciclovir market is segmented into

- Cold Sores

- Genital Herpes

- Shingles

Regional and Country-level Analysis

The Famciclovir market is analysed and market size information is provided by regions (countries).

The key regions covered in the Famciclovir market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Famciclovir Market Share Analysis

Famciclovir market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Famciclovir business, the date to enter into the Famciclovir market, Famciclovir product introduction, recent developments, etc.

The major vendors covered:

- Novartis

- Mylan

- Teva

- Cipla

- Hikma

- Apotex

- Aurobindo Pharma

- Macleods Pharmaceuticals

- Beijing Jialin Pharmaceutical

- HETERO

- Hainan choitec Pharmaceuticals

- Shandong Luoxin Pharmaceutical Group

- Chengdu Diao Pharmaceutical Group

- HISUN

Global and Japan Famciclovir Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Famciclovir Product Introduction
1.2 Market Segments
1.3 Key Famciclovir Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Famciclovir Market Size Growth Rate by Type
1.4.2 125 mg Tablets
1.4.3 250 mg Tablets
1.4.4 500 mg Tablets
1.5 Market by Application
1.5.1 Global Famciclovir Market Size Growth Rate by Application
1.5.2 Cold Sores
1.5.3 Genital Herpes
1.5.4 Shingles
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Famciclovir Market Size, Estimates and Forecasts
2.1.1 Global Famciclovir Revenue 2015-2026
2.1.2 Global Famciclovir Sales 2015-2026
2.2 Global Famciclovir, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Famciclovir Historical Market Size by Region (2015-2020)
2.3.1 Global Famciclovir Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Famciclovir Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Famciclovir Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Famciclovir Sales Forecast by Region (2021-2026)
2.4.2 Global Famciclovir Revenue Forecast by Region (2021-2026)
3 Global Famciclovir Competitor Landscape by Players
3.1 Global Top Famciclovir Sales by Manufacturers
3.1.1 Global Famciclovir Sales by Manufacturers (2015-2020)
3.1.2 Global Famciclovir Sales Market Share by Manufacturers (2015-2020)
3.2 Global Famciclovir Manufacturers by Revenue
3.2.1 Global Famciclovir Revenue by Manufacturers (2015-2020)
3.2.2 Global Famciclovir Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Famciclovir Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Famciclovir Revenue in 2019
3.2.5 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Famciclovir Price by Manufacturers
3.4 Global Famciclovir Manufacturing Base Distribution, Product Types
3.4.1 Famciclovir Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Famciclovir Product Type
3.4.3 Date of International Manufacturers Enter into Famciclovir Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Famciclovir Market Size by Type (2015-2020)
4.1.1 Global Famciclovir Sales by Type (2015-2020)
4.1.2 Global Famciclovir Revenue by Type (2015-2020)
4.1.3 Famciclovir Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Famciclovir Market Size Forecast by Type (2021-2026)
4.2.1 Global Famciclovir Sales Forecast by Type (2021-2026)
4.2.2 Global Famciclovir Revenue Forecast by Type (2021-2026)
4.2.3 Famciclovir Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Famciclovir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Famciclovir Market Size by Application (2015-2020)
5.1.1 Global Famciclovir Sales by Application (2015-2020)
5.1.2 Global Famciclovir Revenue by Application (2015-2020)
5.1.3 Famciclovir Price by Application (2015-2020)
5.2 Famciclovir Market Size Forecast by Application (2021-2026)
5.2.1 Global Famciclovir Sales Forecast by Application (2021-2026)
5.2.2 Global Famciclovir Revenue Forecast by Application (2021-2026)
5.2.3 Global Famciclovir Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Famciclovir Market Size YoY Growth 2015-2026
6.1.1 Japan Famciclovir Sales YoY Growth 2015-2026
6.1.2 Japan Famciclovir Revenue YoY Growth 2015-2026
6.1.3 Japan Famciclovir Market Share in Global Market 2015-2026
6.2 Japan Famciclovir Market Size by Players (International and Local Players)
6.2.1 Japan Top Famciclovir Players by Sales (2015-2020)
6.2.2 Japan Top Famciclovir Players by Revenue (2015-2020)
6.3 Japan Famciclovir Historic Market Review by Type (2015-2020)
6.3.1 Japan Famciclovir Sales Market Share by Type (2015-2020)
6.3.2 Japan Famciclovir Revenue Market Share by Type (2015-2020)
6.3.3 Japan Famciclovir Price by Type (2015-2020)
6.4 Japan Famciclovir Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Famciclovir Sales Forecast by Type (2021-2026)
6.4.2 Japan Famciclovir Revenue Forecast by Type (2021-2026)
6.4.3 Japan Famciclovir Price Forecast by Type (2021-2026)
6.5 Japan Famciclovir Historic Market Review by Application (2015-2020)
6.5.1 Japan Famciclovir Sales Market Share by Application (2015-2020)
6.5.2 Japan Famciclovir Revenue Market Share by Application (2015-2020)
6.5.3 Japan Famciclovir Price by Application (2015-2020)
6.6 Japan Famciclovir Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Famciclovir Sales Forecast by Application (2021-2026)
6.6.2 Japan Famciclovir Revenue Forecast by Application (2021-2026)
6.6.3 Japan Famciclovir Price Forecast by Application (2021-2026)
7 North America
7.1 North America Famciclovir Market Size YoY Growth 2015-2026
7.2 North America Famciclovir Market Facts & Figures by Country
7.2.1 North America Famciclovir Sales by Country (2015-2020)
7.2.2 North America Famciclovir Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Famciclovir Market Size YoY Growth 2015-2026
8.2 Europe Famciclovir Market Facts & Figures by Country
8.2.1 Europe Famciclovir Sales by Country
8.2.2 Europe Famciclovir Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Famciclovir Market Size YoY Growth 2015-2026
9.2 Asia Pacific Famciclovir Market Facts & Figures by Country
9.2.1 Asia Pacific Famciclovir Sales by Region (2015-2020)
9.2.2 Asia Pacific Famciclovir Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Famciclovir Market Size YoY Growth 2015-2026
10.2 Latin America Famciclovir Market Facts & Figures by Country
10.2.1 Latin America Famciclovir Sales by Country
10.2.2 Latin America Famciclovir Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Famciclovir Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Famciclovir Market Facts & Figures by Country
11.2.1 Middle East and Africa Famciclovir Sales by Country
11.2.2 Middle East and Africa Famciclovir Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Famciclovir Products Offered
12.1.5 Novartis Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Description and Business Overview
12.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan Famciclovir Products Offered
12.2.5 Mylan Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Famciclovir Products Offered
12.3.5 Teva Recent Development
12.4 Cipla
12.4.1 Cipla Corporation Information
12.4.2 Cipla Description and Business Overview
12.4.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cipla Famciclovir Products Offered
12.4.5 Cipla Recent Development
12.5 Hikma
12.5.1 Hikma Corporation Information
12.5.2 Hikma Description and Business Overview
12.5.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hikma Famciclovir Products Offered
12.5.5 Hikma Recent Development
12.6 Apotex
12.6.1 Apotex Corporation Information
12.6.2 Apotex Description and Business Overview
12.6.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Apotex Famciclovir Products Offered
12.6.5 Apotex Recent Development
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Corporation Information
12.7.2 Aurobindo Pharma Description and Business Overview
12.7.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aurobindo Pharma Famciclovir Products Offered
12.7.5 Aurobindo Pharma Recent Development
12.8 Macleods Pharmaceuticals
12.8.1 Macleods Pharmaceuticals Corporation Information
12.8.2 Macleods Pharmaceuticals Description and Business Overview
12.8.3 Macleods Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Macleods Pharmaceuticals Famciclovir Products Offered
12.8.5 Macleods Pharmaceuticals Recent Development
12.9 Beijing Jialin Pharmaceutical
12.9.1 Beijing Jialin Pharmaceutical Corporation Information
12.9.2 Beijing Jialin Pharmaceutical Description and Business Overview
12.9.3 Beijing Jialin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Beijing Jialin Pharmaceutical Famciclovir Products Offered
12.9.5 Beijing Jialin Pharmaceutical Recent Development
12.10 HETERO
12.10.1 HETERO Corporation Information
12.10.2 HETERO Description and Business Overview
12.10.3 HETERO Sales, Revenue and Gross Margin (2015-2020)
12.10.4 HETERO Famciclovir Products Offered
12.10.5 HETERO Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Famciclovir Products Offered
12.11.5 Novartis Recent Development
12.12 Shandong Luoxin Pharmaceutical Group
12.12.1 Shandong Luoxin Pharmaceutical Group Corporation Information
12.12.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview
12.12.3 Shandong Luoxin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shandong Luoxin Pharmaceutical Group Products Offered
12.12.5 Shandong Luoxin Pharmaceutical Group Recent Development
12.13 Chengdu Diao Pharmaceutical Group
12.13.1 Chengdu Diao Pharmaceutical Group Corporation Information
12.13.2 Chengdu Diao Pharmaceutical Group Description and Business Overview
12.13.3 Chengdu Diao Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Chengdu Diao Pharmaceutical Group Products Offered
12.13.5 Chengdu Diao Pharmaceutical Group Recent Development
12.14 HISUN
12.14.1 HISUN Corporation Information
12.14.2 HISUN Description and Business Overview
12.14.3 HISUN Sales, Revenue and Gross Margin (2015-2020)
12.14.4 HISUN Products Offered
12.14.5 HISUN Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Famciclovir Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Famciclovir Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Famciclovir Market Segments
Table 2. Ranking of Global Top Famciclovir Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Famciclovir Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 125 mg Tablets
Table 5. Major Manufacturers of 250 mg Tablets
Table 6. Major Manufacturers of 500 mg Tablets
Table 7. Global Famciclovir Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Famciclovir Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Famciclovir Sales by Regions 2015-2020 (K Units)
Table 10. Global Famciclovir Sales Market Share by Regions (2015-2020)
Table 11. Global Famciclovir Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Famciclovir Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Famciclovir Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Famciclovir Sales Share by Manufacturers (2015-2020)
Table 15. Global Famciclovir Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Famciclovir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Famciclovir as of 2019)
Table 17. Famciclovir Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Famciclovir Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Famciclovir Price (2015-2020) (USD/Unit)
Table 20. Famciclovir Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Famciclovir Product Type
Table 22. Date of International Manufacturers Enter into Famciclovir Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Famciclovir Sales by Type (2015-2020) (K Units)
Table 25. Global Famciclovir Sales Share by Type (2015-2020)
Table 26. Global Famciclovir Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Famciclovir Revenue Share by Type (2015-2020)
Table 28. Famciclovir Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Famciclovir Sales Share by Type (2021-2026)
Table 30. Global Famciclovir Sales by Application (2015-2020) (K Units)
Table 31. Global Famciclovir Sales Share by Application (2015-2020)
Table 32. Global Famciclovir Sales Share by Application (2021-2026)
Table 33. Global Famciclovir Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Famciclovir Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Famciclovir Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Famciclovir Sales (K Units) of Key Companies (2015-2020)
Table 37. Japan Famciclovir Sales Share by Company (2015-2020)
Table 38. Japan Famciclovir Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Famciclovir Sales (K Units) by Type (2015-2020)
Table 40. Japan Famciclovir Sales Share by Type (2015-2020)
Table 41. Japan Famciclovir Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Famciclovir Price (K Units) by Type (2015-2020)
Table 43. Japan Famciclovir Sales (K Units) by Type (2021-2026)
Table 44. Japan Famciclovir Sales Share by Type (2021-2026)
Table 45. Japan Famciclovir Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Famciclovir Revenue Share by Type (2021-2026)
Table 47. Japan Famciclovir Price (K Units) by Type (2021-2026)
Table 48. Japan Famciclovir Sales (K Units) by Application (2015-2020)
Table 49. Japan Famciclovir Sales Share by Application (2015-2020)
Table 50. Japan Famciclovir Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Famciclovir Sales (K Units) by Application (2021-2026)
Table 52. Japan Famciclovir Sales Share by Application (2021-2026)
Table 53. Japan Famciclovir Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Famciclovir Revenue Share by Application (2021-2026)
Table 55. North America Famciclovir Sales by Country (2015-2020) (K Units)
Table 56. North America Famciclovir Sales Market Share by Country (2015-2020)
Table 57. North America Famciclovir Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Famciclovir Revenue Market Share by Country (2015-2020)
Table 59. Europe Famciclovir Sales by Country (2015-2020) (K Units)
Table 60. Europe Famciclovir Sales Market Share by Country (2015-2020)
Table 61. Europe Famciclovir Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Famciclovir Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Famciclovir Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Famciclovir Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Famciclovir Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Famciclovir Revenue Market Share by Region (2015-2020)
Table 67. Latin America Famciclovir Sales by Country (2015-2020) (K Units)
Table 68. Latin America Famciclovir Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Famciclovir Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Famciclovir Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Famciclovir Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Famciclovir Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Famciclovir Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Famciclovir Revenue Market Share by Country (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis Famciclovir Product
Table 79. Novartis Recent Development
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Mylan Product
Table 84. Mylan Recent Development
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Teva Product
Table 89. Teva Recent Development
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Cipla Product
Table 94. Cipla Recent Development
Table 95. Hikma Corporation Information
Table 96. Hikma Description and Business Overview
Table 97. Hikma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Hikma Product
Table 99. Hikma Recent Development
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Apotex Product
Table 104. Apotex Recent Development
Table 105. Aurobindo Pharma Corporation Information
Table 106. Aurobindo Pharma Description and Business Overview
Table 107. Aurobindo Pharma Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Aurobindo Pharma Product
Table 109. Aurobindo Pharma Recent Development
Table 110. Macleods Pharmaceuticals Corporation Information
Table 111. Macleods Pharmaceuticals Description and Business Overview
Table 112. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Macleods Pharmaceuticals Product
Table 114. Macleods Pharmaceuticals Recent Development
Table 115. Beijing Jialin Pharmaceutical Corporation Information
Table 116. Beijing Jialin Pharmaceutical Description and Business Overview
Table 117. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Beijing Jialin Pharmaceutical Product
Table 119. Beijing Jialin Pharmaceutical Recent Development
Table 120. HETERO Corporation Information
Table 121. HETERO Description and Business Overview
Table 122. HETERO Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. HETERO Product
Table 124. HETERO Recent Development
Table 125. Hainan choitec Pharmaceuticals Corporation Information
Table 126. Hainan choitec Pharmaceuticals Description and Business Overview
Table 127. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Hainan choitec Pharmaceuticals Product
Table 129. Hainan choitec Pharmaceuticals Recent Development
Table 130. Shandong Luoxin Pharmaceutical Group Corporation Information
Table 131. Shandong Luoxin Pharmaceutical Group Description and Business Overview
Table 132. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Shandong Luoxin Pharmaceutical Group Product
Table 134. Shandong Luoxin Pharmaceutical Group Recent Development
Table 135. Chengdu Diao Pharmaceutical Group Corporation Information
Table 136. Chengdu Diao Pharmaceutical Group Description and Business Overview
Table 137. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Chengdu Diao Pharmaceutical Group Product
Table 139. Chengdu Diao Pharmaceutical Group Recent Development
Table 140. HISUN Corporation Information
Table 141. HISUN Description and Business Overview
Table 142. HISUN Famciclovir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. HISUN Product
Table 144. HISUN Recent Development
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Famciclovir Players
Table 149. Famciclovir Customers List
Table 150. Famciclovir Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Famciclovir Product Picture
Figure 2. Global Famciclovir Sales Market Share by Type in 2020 & 2026
Figure 3. 125 mg Tablets Product Picture
Figure 4. 250 mg Tablets Product Picture
Figure 5. 500 mg Tablets Product Picture
Figure 6. Global Famciclovir Sales Market Share by Application in 2020 & 2026
Figure 7. Cold Sores
Figure 8. Genital Herpes
Figure 9. Shingles
Figure 10. Famciclovir Report Years Considered
Figure 11. Global Famciclovir Market Size 2015-2026 (US$ Million)
Figure 12. Global Famciclovir Sales 2015-2026 (K Units)
Figure 13. Global Famciclovir Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Famciclovir Sales Market Share by Region (2015-2020)
Figure 15. Global Famciclovir Sales Market Share by Region in 2019
Figure 16. Global Famciclovir Revenue Market Share by Region (2015-2020)
Figure 17. Global Famciclovir Revenue Market Share by Region in 2019
Figure 18. Global Famciclovir Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Famciclovir Revenue in 2019
Figure 20. Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Famciclovir Sales Market Share by Type (2015-2020)
Figure 22. Global Famciclovir Sales Market Share by Type in 2019
Figure 23. Global Famciclovir Revenue Market Share by Type (2015-2020)
Figure 24. Global Famciclovir Revenue Market Share by Type in 2019
Figure 25. Global Famciclovir Market Share by Price Range (2015-2020)
Figure 26. Global Famciclovir Sales Market Share by Application (2015-2020)
Figure 27. Global Famciclovir Sales Market Share by Application in 2019
Figure 28. Global Famciclovir Revenue Market Share by Application (2015-2020)
Figure 29. Global Famciclovir Revenue Market Share by Application in 2019
Figure 30. Japan Famciclovir Sales Growth Rate 2015-2026 (K Units)
Figure 31. Japan Famciclovir Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. Japan Famciclovir Market Share in Global Market 2015-2026
Figure 33. Japan 5 and 10 Largest Famciclovir Players Market Share by Revenue in Famciclovir in 2019
Figure 34. Japan Famciclovir Revenue Share by Type (2015-2020)
Figure 35. Japan Famciclovir Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Japan Famciclovir Revenue Share by Application (2015-2020)
Figure 37. Japan Famciclovir Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Famciclovir Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Famciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Famciclovir Sales Market Share by Country in 2019
Figure 41. North America Famciclovir Revenue Market Share by Country in 2019
Figure 42. U.S. Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Famciclovir Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Famciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Famciclovir Sales Market Share by Country in 2019
Figure 49. Europe Famciclovir Revenue Market Share by Country in 2019
Figure 50. Germany Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Famciclovir Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Famciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Famciclovir Sales Market Share by Region in 2019
Figure 63. Asia Pacific Famciclovir Revenue Market Share by Region in 2019
Figure 64. China Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Famciclovir Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Famciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Famciclovir Sales Market Share by Country in 2019
Figure 89. Latin America Famciclovir Revenue Market Share by Country in 2019
Figure 90. Mexico Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Famciclovir Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Famciclovir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Famciclovir Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Famciclovir Revenue Market Share by Country in 2019
Figure 100. Turkey Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Famciclovir Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Famciclovir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Famciclovir Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs